These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25668130)

  • 1. Involvement of the G-protein-coupled receptor 4 in RANKL expression by osteoblasts in an acidic environment.
    Okito A; Nakahama K; Akiyama M; Ono T; Morita I
    Biochem Biophys Res Commun; 2015 Mar; 458(2):435-40. PubMed ID: 25668130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the G-Protein-Coupled Receptor 4 in the Increased Expression of RANK/RANKL/OPG System and Neurotrophins by Nucleus Pulposus Cells under the Degenerated Intervertebral Disc-Like Acidic Microenvironment.
    Li H; Liu H; Zhang N; Zhu Z
    Biomed Res Int; 2020; 2020():1328436. PubMed ID: 32566653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cooperation of CREB and NFAT is required for PTHrP-induced RANKL expression in mouse osteoblastic cells.
    Park HJ; Baek K; Baek JH; Kim HR
    J Cell Physiol; 2015 Mar; 230(3):667-79. PubMed ID: 25187507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluid flow induces Rankl expression in primary murine calvarial osteoblasts.
    Mehrotra M; Saegusa M; Wadhwa S; Voznesensky O; Peterson D; Pilbeam C
    J Cell Biochem; 2006 Aug; 98(5):1271-83. PubMed ID: 16514640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuropeptide VIP regulates the expression of osteoclastogenic factors in osteoblasts.
    Persson E; Lerner UH
    J Cell Biochem; 2011 Dec; 112(12):3732-41. PubMed ID: 21815197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts.
    Tachi K; Takami M; Zhao B; Mochizuki A; Yamada A; Miyamoto Y; Inoue T; Baba K; Kamijo R
    Cell Tissue Res; 2010 Nov; 342(2):213-20. PubMed ID: 20941510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.
    Luo XH; Guo LJ; Xie H; Yuan LQ; Wu XP; Zhou HD; Liao EY
    J Bone Miner Res; 2006 Oct; 21(10):1648-56. PubMed ID: 16995820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression.
    Brechter AB; Lerner UH
    Arthritis Rheum; 2007 Mar; 56(3):910-23. PubMed ID: 17328065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol protects against ethanol-induced bone loss by inhibiting up-regulation of receptor activator of nuclear factor-kappaB ligand in osteoblasts.
    Chen JR; Haley RL; Hidestrand M; Shankar K; Liu X; Lumpkin CK; Simpson PM; Badger TM; Ronis MJ
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1182-90. PubMed ID: 16971503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.
    Iwai K; Koike M; Ohshima S; Miyatake K; Uchiyama Y; Saeki Y; Ishii M
    J Bone Miner Res; 2007 Oct; 22(10):1612-20. PubMed ID: 17576169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-κB ligand in osteoblasts.
    Lee HL; Bae OY; Baek KH; Kwon A; Hwang HR; Qadir AS; Park HJ; Woo KM; Ryoo HM; Baek JH
    Bone; 2011 Aug; 49(2):242-9. PubMed ID: 21514407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of estradiol on ethanol-induced bone loss involve inhibition of reactive oxygen species generation in osteoblasts and downstream activation of the extracellular signal-regulated kinase/signal transducer and activator of transcription 3/receptor activator of nuclear factor-kappaB ligand signaling cascade.
    Chen JR; Shankar K; Nagarajan S; Badger TM; Ronis MJ
    J Pharmacol Exp Ther; 2008 Jan; 324(1):50-9. PubMed ID: 17916759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment.
    Arai A; Mizoguchi T; Harada S; Kobayashi Y; Nakamichi Y; Yasuda H; Penninger JM; Yamada K; Udagawa N; Takahashi N
    J Cell Sci; 2012 Jun; 125(Pt 12):2910-7. PubMed ID: 22454522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential proton sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and G2A expressed in immune cells.
    Radu CG; Nijagal A; McLaughlin J; Wang L; Witte ON
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1632-7. PubMed ID: 15665078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss.
    Wang L; Liu S; Quarles LD; Spurney RF
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E826-34. PubMed ID: 15585587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors.
    Singh PP; van der Kraan AG; Xu J; Gillespie MT; Quinn JM
    Biochem Biophys Res Commun; 2012 May; 422(1):48-53. PubMed ID: 22561018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H; Guo J; Bringhurst FR
    J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.